Vimarsana
Biggest News Aggregation in the World

Page 22 - Valuating News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Valuating. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Valuating Today - Breaking & Trending Today

Orexo announces last patient enrolled in pivotal study evaluating the efficacy of MODIA in combination with sublingual buprenorphine/ naloxone for the treatment of OUD - Vimarsana News

Orexo announces last patient enrolled in pivotal study evaluating the efficacy of MODIA in combination with sublingual buprenorphine/ naloxone for the treatment of OUD

Study evaluating efficacy of MODIA, a digital therapeutic, in addition to clinician supervised medication-assisted treatment programs for individuals with opioid use disorder (OUD)The study

Calliditas Therapeutics: Kidney International Publishes Results from NefIgArd Phase 3 Trial Evaluating TARPEYO (budesonide) in IgA Nephropathy - Vimarsana News

Calliditas Therapeutics: Kidney International Publishes Results from NefIgArd Phase 3 Trial Evaluating TARPEYO (budesonide) in IgA Nephropathy

STOCKHOLM, Oct. 19, 2022 /PRNewswire/ -- Calliditas Therapeutics AB (Nasdaq: CALT) (Nasdaq Stockholm: CALTX) ("Calliditas") today announced Kidney International has published the successful

Helsinn Healthcare S.A.: Helsinn publishes new data evaluating chlormethine gel's mode of action in Dermatology and Therapy - Vimarsana News

Helsinn Healthcare S.A.: Helsinn publishes new data evaluating chlormethine gel's mode of action in Dermatology and Therapy

Helsinn publishes new data evaluating chlormethine gel's mode of action in Dermatology and Therapy Lugano, Switzerland, October 18, 2022 - Helsinn Group ("Helsinn"), a fully integrated, global

India's Adani Enterprises says not evaluating plans to buy Jaiprakash Associates cement unit - Vimarsana News

India's Adani Enterprises says not evaluating plans to buy Jaiprakash Associates cement unit

Indian billionaire Gautam Adani-led Adani Enterprises Ltd on Friday said it was not evaluating a proposal to acquire Jaiprakash Associates Ltd's cement business.... | October 14, 2022

Junshi Biosciences and Coherus Announce Publication of Positive Results from CHOICE-01, a Phase 3 Clinical Trial Evaluating Toripalimab in Combination with Chemotherapy as First-Line Treatment for Non-Small Cell Lung Cancer, in the Journal of Clinical Onc - Vimarsana News

Junshi Biosciences and Coherus Announce Publication of Positive Results from CHOICE-01, a Phase 3 Clinical Trial Evaluating Toripalimab in Combination with Chemotherapy as First-Line Treatment for Non-Small Cell Lung Cancer, in the Journal of Clinical Onc

Toripalimab in combination with chemotherapy was associated with significant improvements in PFS and OS compared with chemotherapy alone in patients with advanced NSCLC without EGFR/ALK mutations, regardless